89bio Total Current Assets vs Accounts Payable Analysis
| ETNB Stock | USD 8.98 0.16 1.75% |
89bio financial indicator trend analysis is way more than just evaluating 89bio Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether 89bio Inc is a good investment. Please check the relationship between 89bio Total Current Assets and its Accounts Payable accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Total Current Assets vs Accounts Payable
Total Current Assets vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of 89bio Inc Total Current Assets account and Accounts Payable. At this time, the significance of the direction appears to have strong relationship.
The correlation between 89bio's Total Current Assets and Accounts Payable is 0.64. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of 89bio Inc, assuming nothing else is changed. The correlation between historical values of 89bio's Total Current Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of 89bio Inc are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Current Assets i.e., 89bio's Total Current Assets and Accounts Payable go up and down completely randomly.
Correlation Coefficient | 0.64 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Accounts Payable
An accounting item on the balance sheet that represents 89bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of 89bio Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.Most indicators from 89bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into 89bio Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, 89bio's Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 385.4 M, whereas Tax Provision is forecasted to decline to 10,000.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 79K | 65K | 49K | 50.6K | Total Operating Expenses | 89.7M | 102.2M | 151.2M | 79.6M |
89bio fundamental ratios Correlations
Click cells to compare fundamentals
89bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
89bio fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 95.6M | 211.1M | 162.4M | 196.8M | 596.3M | 626.1M | |
| Other Current Liab | 4.6M | 6.0M | 10.2M | 11.8M | 20.0M | 10.2M | |
| Total Current Liabilities | 5.6M | 8.1M | 19.5M | 24.6M | 29.6M | 16.8M | |
| Total Stockholder Equity | 89.9M | 203.0M | 126.0M | 151.8M | 536.3M | 563.1M | |
| Net Tangible Assets | 89.9M | 203.0M | 126.0M | 151.8M | 174.6M | 122.0M | |
| Property Plant And Equipment Net | 155K | 166K | 150K | 455K | 2.3M | 2.5M | |
| Net Debt | (93.4M) | (204.7M) | (131.3M) | (35.2M) | (289.1M) | (274.6M) | |
| Retained Earnings | (73.6M) | (123.1M) | (213.2M) | (315.2M) | (457.4M) | (434.6M) | |
| Accounts Payable | 989K | 2.1M | 6.8M | 12.5M | 8.6M | 6.0M | |
| Cash | 93.4M | 204.7M | 150.7M | 55.3M | 316.2M | 332.0M | |
| Non Current Assets Total | 227K | 872K | 440K | 744K | 2.7M | 2.9M | |
| Non Currrent Assets Other | 72K | 706K | 290K | 289K | 396K | 331.1K | |
| Other Assets | 72K | 706K | 290K | 289K | 332.4K | 302.9K | |
| Cash And Short Term Investments | 93.4M | 204.7M | 150.7M | 188.2M | 578.9M | 607.8M | |
| Common Stock Shares Outstanding | 2.3M | 16.1M | 20.1M | 34.8M | 71.2M | 74.7M | |
| Liabilities And Stockholders Equity | 95.6M | 211.1M | 162.4M | 196.8M | 596.3M | 626.1M | |
| Non Current Liabilities Total | 989K | 2.1M | 16.9M | 20.4M | 30.4M | 17.2M | |
| Other Current Assets | 2.0M | 5.6M | 11.3M | 15.8M | 14.7M | 9.1M | |
| Other Stockholder Equity | 163.5M | 326.0M | 339.2M | 467.4M | 993.5M | 1.0B | |
| Total Liab | 5.6M | 8.1M | 36.5M | 45.0M | 60.0M | 33.5M | |
| Net Invested Capital | 89.9M | 203.0M | 145.4M | 171.5M | 561.1M | 589.2M | |
| Property Plant And Equipment Gross | 155K | 166K | 150K | 455K | 2.3M | 2.5M | |
| Total Current Assets | 95.3M | 210.2M | 162.0M | 196.1M | 593.5M | 623.2M | |
| Accumulated Other Comprehensive Income | (95.6M) | (10K) | (64K) | (350K) | 190K | 199.5K | |
| Net Working Capital | 89.7M | 202.1M | 142.4M | 171.5M | 563.9M | 592.1M | |
| Property Plant Equipment | 155K | 166K | 150K | 92K | 105.8K | 131.1K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Return On Assets (0.41) | Return On Equity (0.73) |
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.